FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

96222005: Cannabinol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
159296012 Cannabinol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
840541011 Cannabinol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4736271000241116 cannabinol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cannabinol Is a Marijuana derivative false Inferred relationship Some
Cannabinol Is a Marijuana derivative false Inferred relationship Some
Cannabinol Is a Cannabis (substance) false Inferred relationship Some
Cannabinol Is a cannabinoïde false Inferred relationship Some
Cannabinol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cannabinoid receptor agonist true Inferred relationship Some
Cannabinol Is a Phytocannabinoid (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Delta-9-tetrahydrocannabinol 27mg/mL/cannabinol 25mg/mL buccal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cannabinol Inferred relationship Some
Product containing cannabinol and delta-9-tetrahydrocannabinol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cannabinol Inferred relationship Some 1
Product containing only cannabinol and delta-9-tetrahydrocannabinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cannabinol Inferred relationship Some 1
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Cannabinol Inferred relationship Some 2
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cannabinol Inferred relationship Some 2
Product containing cannabinol and tetrahydrocannabinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cannabinol Inferred relationship Some 2
Product containing cannabinol and tetrahydrocannabinol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cannabinol Inferred relationship Some 2
Product containing only cannabinol and tetrahydrocannabinol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cannabinol Inferred relationship Some 2
Product containing only cannabinol and tetrahydrocannabinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cannabinol Inferred relationship Some 2

This concept is not in any reference sets

Back to Start